Oh, Hamilton Se-Hwee http://orcid.org/0000-0001-8192-7593
Rutledge, Jarod http://orcid.org/0000-0001-7790-2801
Nachun, Daniel
Pálovics, Róbert
Abiose, Olamide
Moran-Losada, Patricia
Channappa, Divya
Urey, Deniz Yagmur
Kim, Kate
Sung, Yun Ju http://orcid.org/0000-0002-8021-4070
Wang, Lihua
Timsina, Jigyasha
Western, Dan http://orcid.org/0000-0003-3725-9553
Liu, Menghan http://orcid.org/0009-0008-9902-5983
Kohlfeld, Pat http://orcid.org/0009-0004-9206-8244
Budde, John
Wilson, Edward N. http://orcid.org/0000-0003-0640-5247
Guen, Yann http://orcid.org/0000-0001-6649-8364
Maurer, Taylor M.
Haney, Michael
Yang, Andrew C. http://orcid.org/0000-0002-6756-4746
He, Zihuai
Greicius, Michael D.
Andreasson, Katrin I. http://orcid.org/0000-0001-8391-4155
Sathyan, Sanish
Weiss, Erica F. http://orcid.org/0000-0002-0726-7547
Milman, Sofiya http://orcid.org/0000-0001-9247-0082
Barzilai, Nir
Cruchaga, Carlos
Wagner, Anthony D. http://orcid.org/0000-0003-0624-4543
Mormino, Elizabeth
Lehallier, Benoit
Henderson, Victor W. http://orcid.org/0000-0003-1198-9240
Longo, Frank M.
Montgomery, Stephen B. http://orcid.org/0000-0002-5200-3903
Wyss-Coray, Tony http://orcid.org/0000-0001-5893-0831
Article History
Received: 19 October 2022
Accepted: 31 October 2023
First Online: 6 December 2023
Competing interests
: T.W-C., H.O., J.R., B.L. and Stanford University have filed a patent application related to this work, PCT/US2023/027896. T.W-C., H.O. and J.R. are co-founders and scientific advisors of Teal Omics Inc. and have received equity stakes. T.W.-C. is a co-founder and scientific advisor of Alkahest Inc. and Qinotto Inc. and has received equity stakes in these companies. C.C. has received research support from GSK and EISAI. The funders of the study had no role in the collection, analysis or interpretation of data; in the writing of the report; nor in the decision to submit the paper for publication. C.C. is a member of the advisory board of Vivid Genomics and Circular Genomics and owns stocks in these companies. S.B.M is a consultant for BioMarin, MyOme and Tenaya Therapeutics. All other authors have certified they have no competing interests to declare.